Michael Dörks1, Stefan Herget-Rosenthal2, Guido Schmiemann3, Falk Hoffmann4. 1. Department of Health Services Research, Carl von Ossietzky University Oldenburg, Ammerländer Heerstrasse 140, 26111, Oldenburg, Germany. michael.doerks@uni-oldenburg.de. 2. Department of Medicine, Rotes Kreuz Hospital, Bremen, Germany. 3. Department of Health Services Research, Institute for Public Health and Nursing Science, University of Bremen, Bremen, Germany. 4. Department of Health Services Research, Carl von Ossietzky University Oldenburg, Ammerländer Heerstrasse 140, 26111, Oldenburg, Germany.
Abstract
BACKGROUND: Polypharmacy has become an emerging public health issue in recent years, since use of multiple medications or polypharmacy is beneficial for many conditions, but may also have negative effects like adverse drug reactions. The risk further increases in patients with chronic renal failure, a comorbidity very frequent in nursing home residents. Since more than 50% of all drugs were renally excreted, dose adjustments in patients with renal failure are required. OBJECTIVE: To assess polypharmacy in German nursing homes, in particular in residents with renal failure. METHODS: Multi-center cross-sectional study in 21 nursing homes in Bremen and Lower Saxony/Germany. Baseline data were analysed using descriptive statistics. Multivariable logistic regression model and 95% confidence intervals were used to study the association of renal failure and polypharmacy. RESULTS: Of all 852 residents, the analysis comprised those 685 with at least one serum creatinine value so that the estimated creatinine clearance could be calculated. Of those, 436 (63.6%) had a severe or moderate renal failure, defined as estimated creatinine clearance <60 mL/min. Polypharmacy (5-9 drugs) was found in 365 (53.3%) and excessive polypharmacy (≥10 drugs) in 112 (16.4%) residents. Diuretics and psycholeptics were the most commonly used drug classes. Severe renal failure (estimated creatinine clearance <30 mL/min) was associated with polypharmacy (OR: 2.8, 95% CI 1.4-5.7). CONCLUSION: Both, polypharmacy and renal failure are common in German nursing home residents and an association of both could be found. Further studies are needed to assess the appropriateness of polypharmacy in these patients.
BACKGROUND: Polypharmacy has become an emerging public health issue in recent years, since use of multiple medications or polypharmacy is beneficial for many conditions, but may also have negative effects like adverse drug reactions. The risk further increases in patients with chronic renal failure, a comorbidity very frequent in nursing home residents. Since more than 50% of all drugs were renally excreted, dose adjustments in patients with renal failure are required. OBJECTIVE: To assess polypharmacy in German nursing homes, in particular in residents with renal failure. METHODS: Multi-center cross-sectional study in 21 nursing homes in Bremen and Lower Saxony/Germany. Baseline data were analysed using descriptive statistics. Multivariable logistic regression model and 95% confidence intervals were used to study the association of renal failure and polypharmacy. RESULTS: Of all 852 residents, the analysis comprised those 685 with at least one serum creatinine value so that the estimated creatinine clearance could be calculated. Of those, 436 (63.6%) had a severe or moderate renal failure, defined as estimated creatinine clearance <60 mL/min. Polypharmacy (5-9 drugs) was found in 365 (53.3%) and excessive polypharmacy (≥10 drugs) in 112 (16.4%) residents. Diuretics and psycholeptics were the most commonly used drug classes. Severe renal failure (estimated creatinine clearance <30 mL/min) was associated with polypharmacy (OR: 2.8, 95% CI 1.4-5.7). CONCLUSION: Both, polypharmacy and renal failure are common in German nursing home residents and an association of both could be found. Further studies are needed to assess the appropriateness of polypharmacy in these patients.
Authors: Falk Hoffmann; Hanna Kaduszkiewicz; Gerd Glaeske; Hendrik van den Bussche; Daniela Koller Journal: Aging Clin Exp Res Date: 2014-03-20 Impact factor: 3.636
Authors: Joseph T Hanlon; Xiaoqiang Wang; Steven M Handler; Steven Weisbord; Mary Jo Pugh; Todd Semla; Roslyn A Stone; Sherrie L Aspinall Journal: J Am Med Dir Assoc Date: 2010-10-02 Impact factor: 4.669
Authors: John Schnelle; Dan Osterweil; Denise Globe; Angela Sciarra; Paul Audhya; Arie Barlev Journal: J Am Med Dir Assoc Date: 2008-12-20 Impact factor: 4.669
Authors: Michiel C Meulendijk; Marco R Spruit; A Clara Drenth-van Maanen; Mattijs E Numans; Sjaak Brinkkemper; Paul A F Jansen; Wilma Knol Journal: Drugs Aging Date: 2015-06 Impact factor: 3.923
Authors: Alys W Griffiths; Claire A Surr; David P Alldred; John Baker; Ruchi Higham; Karen Spilsbury; Carl A Thompson Journal: Int J Clin Pharm Date: 2019-07-24